EN
overview

Stemmatters is a biotechnology company focused on regenerative medicine.


Stemmatters has therapeutic development programs in cartilage repair, osteoarthritis management and spinal cord injury repair. The company also provides contract manufacturing services regarding tissue processing, manufacturing (cells and cell based products), and stem cell banking.


Stemmatters is registered as SME with EMA since 2012.

VISION

To become a global enabler of regenerative medicine by offering 

integrated manufacturing solutions and novel platforms for cellular based products.

MISSION

Our mission is to provide customized manufacturing and novel regenerative medicine products that help people counteracting degenerative and traumatic medical conditions.

EXECUTIVE MANAGEMENT
RUI L. REIS
President and CSO

Rui is a Full Professor of Tissue Engineering, Regenerative Medicine and Stem Cells at the Department of Polymer Engineering, School of Engineering of University of Minho (UM), being the Director of the 3B's Research Group - Biomaterials, Biodegradables and Biomimetics at the U. Minho in Portugal. His vast research experience covers the development and combination of natural origin biomaterials  with stem cells in the context of tissue engineering and regenerative medicine. 


RUI A. SOUSA
CEO

Rui obtained a first degree in Metallurgical and Materials Engineering by University of Porto and a PhD by Brunel University in 2002. He worked in industry and consultancy settings, where he acquired experience in several business and technology domains. Rui returned to academia in 2005 where he further pursued research interests in tissue engineering and Regenerative Medicine, before integrating Stemmatters. He also holds an MBA and received training in several scientific and management areas.